acute coronary syndrome, anticoagulant therapy, article, bleeding, coronary artery bypass graft, drug efficacy, drug safety, human, phase 2 clinical trial (topic), phase 3 clinical trial (topic), priority journal, risk benefit analysis,
European Heart Journal
Erasmus MC: University Medical Center Rotterdam

Verheugt, F.W.A, Clemmensen, P, Mehran, R, Agewall, S, Pocock, S.J, Goldstein, S.L, … Zannad, F. (2013). Antithrombotic outcome trials in acute coronary syndromes: Seeking the optimal balance between safety and efficacy. European Heart Journal, 34(22), 1621–1629. doi:10.1093/eurheartj/eht013